Poseida Therapeutics, Inc.: SCHEDULE 13D/A filed Jan 13, 2025

Form type

SCHEDULE 13D/A

Filing date

Jan 13, 2025

Accession number

0000902664-25-000190

Filer

Poseida Therapeutics, Inc. (CIK 1661460)